Jun 9, 2017

New cancer drug attacks tumors regardless of where they are

Live cancer before treatment (l)/ Dead cancer after treatment (r)

A new study found tumors with a certain marker can be targeted by the drug pembrolizumab regardless of where they are in the body. The drug's success led the FDA to grant it accelerated approval in May — as many as 60,000 adults and children could benefit per year.

"As there is now a treatment option for these patients, potentially all advanced solid tumor patients should be tested," Dung Thi Le, study author and oncologist at Johns Hopkins.

Study details: 86 patients with solid tumors were given the drug Keytruda. They were all in advanced stages of different types of cancer but had the same genetic marker (MMR) that essentially affects the ability of cells to recognize and repair mistakes that can occur as cells grow and divide. The patients had already unsuccessfully tried at least one other type of therapy. The 12 types of cancers treated included colorectal, endometrial, pancreatic, prostate, small intestine, and thyroid. Theodora Ross, an oncologist at UT Southwestern Medical Center who did not participate in the study, says, "The exciting thing about this is that this genetic marker of MMR deficiency works much better and doesn't just work in colon cancer."Study results: After receiving the drug, 66 patients had their tumors shrink substantially and stabilize, instead of continuing to grow. Among them were 18 patients whose tumors vanished and have not returned. 20 patients continued to showprogression in their disease or died from it during the study.Background: PD-1 is a checkpoint protein on T cells (one of the body's immune cells) that normally acts as a type of "off switch" that stops the T cells from attacking other cells. The protein works by attaching itself to another called PD-L1, basically telling the T cell to leave the other cell alone. Some cancer cells have large amounts of PD-L1, which help them evade immune attack.

Until recently, PD-1 blockade therapies were only approved for a select few classes of cancers. As the NYT pointed out, this study was the result of a failed trial by a similar drug in which only one patient was successfully treated — later found to be due to the genetic marker. And, the American Cancer Society says antibodies that block either the PD-1 or PD-L1 "have shown a great deal of promise in treating certain cancers."

Moving forward: Le said she would like to continue investigating the use of PD-1 inhibitors in untreated patients and resected tumors with high risk.

Hereditary factors: Ross added that the fact that the study showed almost 50% of patients had hereditary mutations means genetic testing could have helped the patients take preventative measures before cancer progressed.

Go deeper

Trump signs $2 trillion relief bill as U.S. coronavirus case count tops 100,000

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Andrew Witherspoon/Axios

President Trump signed a $2.2 trillion coronavirus relief package on Friday, as infections in the U.S. topped 100,000 and more cities experience spikes of the novel coronavirus.

The big picture: The U.S. has the most COVID-19 cases in the world, exceeding China and Italy, per data from Johns Hopkins. A second wave of American cities, including Boston, Detroit, New Orleans and Philadelphia, are reporting influxes of cases.

Go deeperArrowUpdated 7 hours ago - Health

Coronavirus updates: Italy records deadliest day with nearly 1,000 dead

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens and confirmed plus presumptive cases from the CDC

Italy on Friday reported 969 COVID-19 deaths over a 24-hour period, marking the deadliest single-day for the country since the global outbreak began, according to data from the Health Ministry.

The big picture: The U.S. now leads the world in confirmed coronavirus cases, as the number of global cases nears 600,000. Governments around the world are trying to curb the medical and financial fallout of COVID-19, as infections surge across Europe and the U.S.

Go deeperArrowUpdated 8 hours ago - Health

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 9 p.m. ET: 595,800 — Total deaths: 27,324 — Total recoveries: 131,006.
  2. U.S.: Leads the world in cases. Total confirmed cases as of 9 p.m. ET: 103,942 — Total deaths: 1,689 — Total recoveries: 870.
  3. Federal government latest: President Trump signed the $2 trillion coronavirus stimulus bill to provide businesses and U.S. workers economic relief.
  4. State updates: Nearly 92% of cities do not have adequate medical supplies — New York is trying to nearly triple its hospital capacity in less than a month.
  5. World updates: Italy reported 969 coronavirus deaths on Friday, the country's deadliest day.
  6. Business latest: President Trump authorized the use of the Defense Production Act to direct General Motors to build ventilators for those affected by COVID-19. White House trade adviser Peter Navarro has been appointed to enforce the act.
  7. 🏰 1 Disney thing: Both Disney World and Disneyland theme parks in the U.S. are closed until further notice.
  8. What should I do? Answers about the virus from Axios expertsWhat to know about social distancing.
  9. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.